[October 07, 2004] PhysioAdvantage to Present at Windhover Information and Medtech Insight's ``Investment In Innovation'' Conference MIDLOTHIAN, Va. --(Business Wire)-- Oct. 7, 2004 -- PhysioAdvantage will be presenting on October 22, 2004 at Windhover Information and Medtech Insight's Prestigious "Investment In Innovation" Event, taking place October 21-22, 2004 at the Westin Copley Place Hotel in Boston, Massachusetts. PhysioAdvantage is a healthcare technology company dedicated to simplifying critical care patient management. Physio's innovative products provide continuous non-invasive monitoring for pulse oximetry, core temperature, brain activity, and peripheral circulation. Approximately 83,000 ICU beds in US hospitals are used to monitor these conditions for 23 million patients annually. European and Pacific Rim opportunities add approximately 91,000 beds and 22 million patients. The ICU markets described exceed $1 billion. Physio's newest technology provides feedback on core body temperature and peripheral circulation via a disposable, transdermal sensor array designed for single patient use. The sensor technology allows placement on virtually any area of the body as easily as placement of a band-aid, and it can remain in place indefinitely. It is the first measurement device that can reliably monitor core temperature and peripheral circulation on an unattended, continuous basis in an entirely non-invasive manner. A breakthrough alternative to maximally invasive rectal and esophageal probes, the Physio patches measure core body temperature with maximal ease. The patient-friendly and user-friendly, peel'n'stick sensor array can be used to continuously evaluate and recognize critical care patient changes associated with such conditions as sepsis and peripheral circulation (deep vein thrombosis), as well as cardiac output. A wireless form of the sensor can be used to drive a number of consumer healthcare markets where important information can be obtained by continuously monitoring core body temperature via a disposable, transdermal patch. The technology allows for easy placement without the assistance of a trained clinician. Examples of consumer market applications include ovulation monitoring and infant fever monitoring. Both are substantial markets dominated today by spot-checking technology. The availability of a reliable, non-invasive means to provide continuous data will meet the test of satisfying a pervasive consumer need with convenience and value. Qualitative and quantitative concept testing has revealed substantial demand, purchase intent and opportunity within medical, as well as, consumer markets. PhysioAdvantage is seeking marketing and distribution partners for preparation of the described technology in its final commercial form. About Medtech Insight Medtech Insight's "Investment In Innovation" conferences are considered the premier forum for senior executives in the investment and medical technology community to preview emerging medtech companies in need of funding, acquisition and/or strategic partnership. Medtech Insight, which was recently acquired by Windhover Information Inc. (www.windhover.com), publisher of "IN VIVO: The Business & Medicine Report," "Start-UP: Windhover's Review of Emerging Technologies," and "IN VIVO EuropeRx," offers a wide variety of products and services for the medical technology executive. In addition to conferences, the company publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry, as well as analyses of medtech markets through its Reports group, and offers custom consulting and market research. To register for the Boston conference or for more information on Medtech Insight, please call Scott Pantel at 949-219-0150 or 888-290-2225 toll-free in the U.S., e-mail [email protected], or visit http://www.medtechinsight.com/in3-12.html. [ Back To TMCnet.com's Homepage ]